Research News

- Read more about Ebola Virus Disease can be diagnosed by New 'Finger-Prick Test' Within Minutes
A diagnostic test for Ebola can accurately predict within minutes if an individual has Ebola Virus Disease (EVD). The study is published in The Lancet.
- Read more about Blood Test may Detect Pancreatic Cancer at early stage
Scientists, including one of the Indian-origin, have found a blood test effective in detecting early pancreatic cancer in human as it is often diagnosed in the later stages. The report appeared in the journal Nature.
- Read more about World Health Organization stated: Insecticide Lindane, DDT may Cause Cancer
The World Health Organization (WHO) has revealed that lindane, an insecticide, widely used in agriculture and to treat human lice and scabies, can cause cancer and associated to occurrence of non-Hodgkin lymphoma, a rare kind of cancer. International Agency for Research in Cancer (IARC's) specialist panel classified lindane as "carcinogenic to humans" in its Group 1 category, DDT as "probably carcinogenic to humans" in its Group 2A class, and the herbicide 2,4-D as "possibly carcinogenic to humans" in its Group 2B.
- Read more about Skin Cancer Drug may Slow Age-Related Deaths
Scientist have found that a drug used to treat skin cancer may slow the onset of age-related deaths by slowing the aging process in fruit flies. The study was printed in the journal Cell.
- Read more about Head and Neck Cancers can be detected by New Test That Uses Blood and Saliva
Head and neck cancers affect nearly 50,000 people in the United States each year. The main risk factors include alcohol, smoking and human papillomavirus (HPV), a common sexually transmitted infection that often goes undetected. Researchers at Johns Hopkins University have developed a new test that uses blood and saliva to detect head and neck cancers. The research is published in Science Translational Medicine.
1 July 2015

Blood Pressure Drug may be Helpful in Cocaine & Alcohol Deaddiction

A drug helpful in treating high blood pressure is now effective in ceasing cocaine and alcohol addiction in animal models. This new research give hopes to millions of addicts around the world. Anti-hypertensive drugs block a particular type of ion channel, which is expressed not only in heart and blood vessels but also in certain brain cells. The researchers found that blocking these ion channels in brain cells, using a drug called isradipine, appears to reverse the rewiring that underlies memories of addiction-associated places. The research is published in the Molecular Psychiatry.
- Read more about Test detects every known human virus from single drop of blood
Researchers have developed a new test that can detect every known human virus that currently or previously infected a person from a single drop of blood. The method developed by Howard Hughes Medical Institute (HHMI) researchers can test for current and past infections with any known human virus, including HIV and hepatitis C.
- Read more about USFDA approved Impax Specialty Pharma's Zomig Nasal Spray for Migraine
The United States Food and Drug Administration has approved Impax Specialty Pharma's Zomig Nasal Spray for treatment of acute migraine with or without aura in pediatric patients who are 12 years and older.
- Read more about Rheumatoid Arthritis Drug Restores Skin Color in Vitiligo Patient
Vitiligo is a common, psychologically devastating condition that causes skin to lose its pigmentation or color. Current treatments, such as steroid creams and light therapy, are not reliably effective in reversing the disease. A new study says, a drug used for treating rheumatoid arthritis has restored skin color in a female patient suffering from vitiligo -- a common, skin condition where portion of skin loses its pigmentation or color. The report was published in JAMA Dermatology.
- Read more about Researchers found Potential cure for Type 2 Diabetes
Researchers from the Laboratory of Cancer Metabolism at IDIBELL found a potential target for the treatment of type 2 diabetes. The study is published in the Journal of Clinical Investigation. Research led by Sara Kozma, have shown in animal models that inhibition of S6K1 protein may be a potential treatment for type 2 diabetes.